SynthesisZeitschrift fur Rheumatologie2026

Indirect comparative efficacy and safety of belimumab vs. anifrolumab in systemic lupus erythematosus and lupus nephritis: a meta-analysis of randomized trials.

Young Ho Lee et al.PubMed ↗Publisher ↗

No numbers read from the abstract.